These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 15848550

  • 1. Sirolimus delays recovery from posttransplant renal failure in kidney graft recipients.
    Boratyńska M, Banasik M, Patrzalek D, Szyber P, Klinger M.
    Transplant Proc; 2005 Mar; 37(2):839-42. PubMed ID: 15848550
    [Abstract] [Full Text] [Related]

  • 2. Impact of sirolimus treatment in kidney allograft recipients with prolonged cold ischemia times: 5-year outcomes.
    Boratynska M, Banasik M, Patrzalek D, Klinger M.
    Exp Clin Transplant; 2008 Mar; 6(1):59-66. PubMed ID: 18405247
    [Abstract] [Full Text] [Related]

  • 3. The combination of sirolimus and cyclosporine does not delay initial renal graft function recovery.
    Hsu HJ, Tian YC, Chen YC, Lai BC, Fang JT, Yang CW, Wu MS.
    Ren Fail; 2008 Mar; 30(3):303-6. PubMed ID: 18350450
    [Abstract] [Full Text] [Related]

  • 4. Graft outcome in cadaver renal transplants treated with full-dose cyclosporine induction without antibody, irrespective of graft function.
    Douzdjian V, Bhaskar S, Baliga PK, Rajagopalan PR.
    Clin Transplant; 1997 Aug; 11(4):294-8. PubMed ID: 9267718
    [Abstract] [Full Text] [Related]

  • 5. Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
    Oberbauer R, Kreis H, Johnson RW, Mota A, Claesson K, Ruiz JC, Wilczek H, Jamieson N, Henriques AC, Paczek L, Chapman J, Burke JT, Rapamune Maintenance Regimen Study Group.
    Transplantation; 2003 Jul 27; 76(2):364-70. PubMed ID: 12883194
    [Abstract] [Full Text] [Related]

  • 6. Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus.
    Albano L, Berthoux F, Moal MC, Rostaing L, Legendre C, Genin R, Toupance O, Moulin B, Merville P, Rerolle JP, Bayle F, Westeel PF, Glotz D, Kossari N, Lefrançois N, Charpentier B, Blanc AS, Di Giambattista F, Dantal J, RAD A2420 Study Group.
    Transplantation; 2009 Jul 15; 88(1):69-76. PubMed ID: 19584683
    [Abstract] [Full Text] [Related]

  • 7. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients.
    Morales JM, Campistol JM, Kreis H, Mourad G, Eris J, Schena FP, Grinyo JM, Nanni G, Andres A, Castaing N, Brault Y, Burke JT.
    Transplant Proc; 2005 Mar 15; 37(2):693-6. PubMed ID: 15848504
    [Abstract] [Full Text] [Related]

  • 8. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A.
    Acta Med Port; 2004 Mar 15; 17(1):8-14. PubMed ID: 15636737
    [Abstract] [Full Text] [Related]

  • 9. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO, Kahan BD, Van Buren C, Schulman SL, Scarola J, Neylan JF, Sirolimus High-Risk Study Group.
    Transplantation; 2008 Nov 15; 86(9):1187-95. PubMed ID: 19005398
    [Abstract] [Full Text] [Related]

  • 10. Renal transplants with delayed graft function show decreased renal function despite monitoring with postabsorptive levels.
    Dominguez J, Gonzalez A, Crossley N, Norambuena R.
    Transplant Proc; 2004 Nov 15; 36(6):1655-8. PubMed ID: 15350442
    [Abstract] [Full Text] [Related]

  • 11. Delayed graft function has an equally bad impact on deceased donor renal graft survival in both standard criteria donors and expanded criteria donors.
    Hassanain M, Tchervenkov J, Cantarovich M, Metrakos P, Paraskevas S, Keith D, Baran D, Fernandez M, Mangel R, Chaudhury P.
    Transplant Proc; 2009 Nov 15; 41(1):133-4. PubMed ID: 19249497
    [Abstract] [Full Text] [Related]

  • 12. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients.
    Boratyńska M, Banasik M, Watorek E, Falkiewicz K, Patrzałek D, Szyber P, Klinger M.
    Transplant Proc; 2006 Nov 15; 38(1):101-4. PubMed ID: 16504675
    [Abstract] [Full Text] [Related]

  • 13. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov 15; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 14. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A, Woo KT.
    Clin Transpl; 1999 Nov 15; ():189-97. PubMed ID: 11038637
    [Abstract] [Full Text] [Related]

  • 15. A phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients.
    Baboolal K.
    Transplantation; 2003 Apr 27; 75(8):1404-8. PubMed ID: 12717239
    [Abstract] [Full Text] [Related]

  • 16. Importance of early adequate exposure to cyclosporine in renal transplant outcome: study of 1-year creatinine.
    Dominguez J, Kompatzki A, Velasco A, Turpaud F, Norambuena R, Arenas J, Pais E, Llanos R, Cortes-Monroy G.
    Transplant Proc; 2005 Oct 27; 37(8):3358-60. PubMed ID: 16298595
    [Abstract] [Full Text] [Related]

  • 17. Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine.
    Romagnoli J, Citterio F, Nanni G, Favi E, Tondolo V, Spagnoletti G, Salerno MP, Castagneto M.
    Transplant Proc; 2006 May 27; 38(4):1034-6. PubMed ID: 16757255
    [Abstract] [Full Text] [Related]

  • 18. Delayed graft function in renal transplant recipients: risk factors and impact on 1-year graft function: a single center analysis.
    Bronzatto EJ, da Silva Quadros KR, Santos RL, Alves-Filho G, Mazzali M.
    Transplant Proc; 2009 Apr 27; 41(3):849-51. PubMed ID: 19376369
    [Abstract] [Full Text] [Related]

  • 19. The long-term effect of delayed graft function on cadaveric renal transplants treated with low-dose cyclosporine.
    Miwa H, Van Loenen M, Vanderwerf BA.
    Clin Transpl; 1989 Apr 27; ():275-80. PubMed ID: 2487572
    [Abstract] [Full Text] [Related]

  • 20. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ, Duhart BT, Krauss AG, Moore LW, Egidi MF, Amiri HS, Gaber LW, Gaber AO.
    Transplantation; 2008 Jul 27; 86(2):313-20. PubMed ID: 18645496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.